{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:56:30Z","timestamp":1786769790822,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["label 2021"],"award-info":[{"award-number":["label 2021"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006331","name":"Cancerop\u00f4le PACA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The targeting of cancer stem cells (CSCs) has proven to be an effective approach for limiting tumor progression, thus necessitating the identification of new drugs with anti-CSC activity. Through a high-throughput drug repositioning screen, we identify the antibiotic Nifuroxazide (NIF) as a potent anti-CSC compound. Utilizing a click chemistry strategy, we demonstrate that NIF is a prodrug that is specifically bioactivated in breast CSCs. Mechanistically, NIF-induced CSC death is a result of a synergistic action that combines the generation of DNA interstrand crosslinks with the inhibition of the Fanconi anemia (FA) pathway activity. NIF treatment mimics FA-deficiency through the inhibition of STAT3, which we identify as a non-canonical transcription factor of FA-related genes. NIF induces a chemical HRDness (Homologous Recombination Deficiency) in CSCs that (re)sensitizes breast cancers with innate or acquired resistance to PARP inhibitor (PARPi) in patient-derived xenograft models. Our results suggest that NIF may be useful in combination with PARPi for the treatment of breast tumors, regardless of their HRD status.<\/jats:p>","DOI":"10.1038\/s41467-025-57476-4","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:46:36Z","timestamp":1741067196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibition of the STAT3\/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7024-0733","authenticated-orcid":false,"given":"Celia D.","family":"Rouault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Bansard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-2228","authenticated-orcid":false,"given":"Elena","family":"Mart\u00ednez-Balsalobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0516-777X","authenticated-orcid":false,"given":"Julien","family":"Wicinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5823-2603","authenticated-orcid":false,"given":"Ludovic","family":"Colombeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Debieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7841-7250","authenticated-orcid":false,"given":"Guillaume","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Machu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3020-910X","authenticated-orcid":false,"given":"Olivier","family":"Rosnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Chevrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-3127","authenticated-orcid":false,"given":"Cornel","family":"Popovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagay","family":"Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-9318","authenticated-orcid":false,"given":"Geraldine","family":"Guasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-446X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pannequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Pascussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-1619","authenticated-orcid":false,"given":"Christophe","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Charafe-Jauffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-3837","authenticated-orcid":false,"given":"Christophe","family":"Ginestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"57476_CR1","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57476_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2007","unstructured":"O\u2019Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106\u2013110 (2007).","journal-title":"Nature"},{"key":"57476_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"57476_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier, C. et al. ALDH1 Is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555\u2013567 (2007).","journal-title":"Cell Stem Cell"},{"key":"57476_CR5","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086\u20131093 (2011).","journal-title":"Nat. Med."},{"key":"57476_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2011.02.020","volume":"8","author":"A Merlos-Su\u00e1rez","year":"2011","unstructured":"Merlos-Su\u00e1rez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511\u2013524 (2011).","journal-title":"Cell Stem Cell"},{"key":"57476_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"57476_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"57476_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker, G. S. et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat. Genet. 52, 1208\u20131218 (2020).","journal-title":"Nat. Genet."},{"key":"57476_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"57476_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta, P. B. et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645\u2013659 (2009).","journal-title":"Cell"},{"key":"57476_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai, T. T. et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat. Chem. 9, 1025\u20131033 (2017).","journal-title":"Nat. Chem."},{"key":"57476_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI39397","volume":"120","author":"C Ginestier","year":"2010","unstructured":"Ginestier, C. et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Investig. 120, 485\u2013497 (2010).","journal-title":"J. Clin. Investig."},{"key":"57476_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.molcel.2012.06.014","volume":"47","author":"H Korkaya","year":"2012","unstructured":"Korkaya, H. et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 47, 570\u2013584 (2012).","journal-title":"Mol. Cell"},{"key":"57476_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch, A. et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 23, 811\u2013825 (2013).","journal-title":"Cancer Cell"},{"key":"57476_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.stemcr.2022.02.005","volume":"17","author":"L Bansard","year":"2022","unstructured":"Bansard, L. et al. Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy. Stem Cell Rep. 17, 835\u2013848 (2022).","journal-title":"Stem Cell Rep."},{"key":"57476_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-023-06367-z","volume":"620","author":"PA Cassier","year":"2023","unstructured":"Cassier, P. A. et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature 620, 409\u2013416 (2023).","journal-title":"Nature"},{"key":"57476_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand, J. et al. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature 620, 402\u2013408 (2023).","journal-title":"Nature"},{"key":"57476_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nrd3405","volume":"10","author":"F Pammolli","year":"2011","unstructured":"Pammolli, F., Magazzini, L. & Riccaboni, M. The productivity crisis in pharmaceutical R&D. Nat. Rev. Drug Discov. 10, 428\u2013438 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"57476_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"57476_CR21","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe, N. et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat. Rev. Clin. Oncol. 12, 445\u2013464 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"57476_CR22","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.celrep.2017.02.016","volume":"18","author":"R El Helou","year":"2017","unstructured":"El Helou, R. et al. miR-600 acts as a bimodal switch that regulates breast cancer stem cell fate through WNT signaling. Cell Rep. 18, 2256\u20132268 (2017).","journal-title":"Cell Rep."},{"key":"57476_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809930","volume":"11","author":"A Arfaoui","year":"2019","unstructured":"Arfaoui, A. et al. A genome\u2010wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells. EMBO Mol. Med. 11, e9930 (2019).","journal-title":"EMBO Mol. Med."},{"key":"57476_CR24","first-page":"665","volume":"2","author":"P Murthy","year":"2019","unstructured":"Murthy, P. & Muggia, F. PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues. Cancer Drug Resist. 2, 665\u2013679 (2019).","journal-title":"Cancer Drug Resist."},{"key":"57476_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(23)01055-3","volume":"402","author":"N Agarwal","year":"2023","unstructured":"Agarwal, N. et al. Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial. Lancet 402, 291\u2013303 (2023).","journal-title":"Lancet"},{"key":"57476_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.mcb.2022.02.008","volume":"170","author":"G Pinna","year":"2022","unstructured":"Pinna, G., Vandamme, M., Rouault, C., Charafe-Jauffret, E. & Ginestier, C. Genome-wide RNA interference screen in cancer stem cells. Methods Cell Biol. 170, 81\u201399 (2022).","journal-title":"Methods Cell Biol."},{"key":"57476_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","volume":"69","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302\u20131313 (2009).","journal-title":"Cancer Res."},{"key":"57476_CR28","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1158\/0008-5472.CAN-15-1497","volume":"76","author":"J Giraud","year":"2016","unstructured":"Giraud, J. et al. Autocrine secretion of progastrin promotes the survival and self-renewal of colon cancer stem-like cells. Cancer Res. 76, 3618\u20133628 (2016).","journal-title":"Cancer Res."},{"key":"57476_CR29","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-15-2157","volume":"23","author":"PH Nguyen","year":"2017","unstructured":"Nguyen, P. H. et al. Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma. Clin. Cancer Res. 23, 1586\u20131597 (2017).","journal-title":"Clin. Cancer Res."},{"key":"57476_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"57476_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.chembiol.2012.05.017","volume":"19","author":"L Zhou","year":"2012","unstructured":"Zhou, L. et al. ALDH2 mediates 5-nitrofuran activity in multiple species. Chem. Biol. 19, 883\u2013892 (2012).","journal-title":"Chem. Biol."},{"key":"57476_CR32","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.chembiol.2018.09.005","volume":"25","author":"S Sarvi","year":"2018","unstructured":"Sarvi, S. et al. ALDH1 bio-activates nifuroxazide to eradicate ALDHHigh melanoma-initiating cells. Cell Chem. Biol. 25, 1456\u20131469.e6 (2018).","journal-title":"Cell Chem. Biol."},{"key":"57476_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/em.2860050512","volume":"5","author":"DR McCalla","year":"1983","unstructured":"McCalla, D. R. Mutagenicity of nitrofuran derivatives: review. Environ. Mutagen 5, 745\u2013765 (1983).","journal-title":"Environ. Mutagen"},{"key":"57476_CR34","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/jsfa.6024","volume":"93","author":"F Gao","year":"2013","unstructured":"Gao, F. et al. Residue depletion of nifuroxazide in broiler chicken: depletion of nifuroxazide in broiler chicken. J. Sci. Food Agric. 93, 2172\u20132178 (2013).","journal-title":"J. Sci. Food Agric."},{"key":"57476_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41570-018-0030-x","volume":"2","author":"T Ca\u00f1eque","year":"2018","unstructured":"Ca\u00f1eque, T., M\u00fcller, S. & Rodriguez, R. Visualizing biologically active small molecules in cells using click chemistry. Nat. Rev. Chem. 2, 202\u2013215 (2018).","journal-title":"Nat. Rev. Chem."},{"key":"57476_CR36","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/nprot.2015.066","volume":"10","author":"JV Forment","year":"2015","unstructured":"Forment, J. V. & Jackson, S. P. A flow cytometry\u2013based method to simplify the analysis and quantification of protein association to chromatin in mammalian cells. Nat. Protoc. 10, 1297\u20131307 (2015).","journal-title":"Nat. Protoc."},{"key":"57476_CR37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.cell.2016.09.053","volume":"167","author":"S Hamperl","year":"2016","unstructured":"Hamperl, S. & Cimprich, K. A. Conflict resolution in the genome: how transcription and replication make it work. Cell 167, 1455\u20131467 (2016).","journal-title":"Cell"},{"key":"57476_CR38","doi-asserted-by":"publisher","first-page":"47759","DOI":"10.1074\/jbc.C100569200","volume":"276","author":"IM Ward","year":"2001","unstructured":"Ward, I. M. & Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276, 47759\u201347762 (2001).","journal-title":"J. Biol. Chem."},{"key":"57476_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04538-w","volume":"13","author":"V Azzoni","year":"2022","unstructured":"Azzoni, V. et al. BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells. Cell Death Dis. 13, 96 (2022).","journal-title":"Cell Death Dis."},{"key":"57476_CR40","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1182\/blood.V85.8.2233.bloodjournal8582233","volume":"85","author":"H Seyschab","year":"1995","unstructured":"Seyschab, H. et al. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 85, 2233\u20132237 (1995).","journal-title":"Blood"},{"key":"57476_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","volume":"668","author":"AD Auerbach","year":"2009","unstructured":"Auerbach, A. D. Fanconi anemia and its diagnosis. Mutat. Res. 668, 4\u201310 (2009).","journal-title":"Mutat. Res."},{"key":"57476_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2017.04.021","volume":"66","author":"L Feeney","year":"2017","unstructured":"Feeney, L. et al. RPA-mediated recruitment of the E3 ligase RFWD3 is vital for interstrand crosslink repair and human health. Mol. Cell 66, 610\u2013621.e4 (2017).","journal-title":"Mol. Cell"},{"key":"57476_CR43","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1093\/nar\/gkad559","volume":"51","author":"S Berrada","year":"2023","unstructured":"Berrada, S. et al. A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cells. Nucleic Acids Res. 51, 7988\u20138004, https:\/\/doi.org\/10.1093\/nar\/gkad559 (2023).","journal-title":"Nucleic Acids Res."},{"key":"57476_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi, R., Sarangi, P. & D\u2019Andrea, A. D. The Fanconi anaemia pathway: new players and new functions. Nat. Rev. Mol. Cell Biol. 17, 337\u2013349 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"57476_CR45","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1126\/science.1182372","volume":"326","author":"P Knipscheer","year":"2009","unstructured":"Knipscheer, P. et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 326, 1698\u20131701 (2009).","journal-title":"Science"},{"key":"57476_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","volume":"3","author":"J Niraj","year":"2019","unstructured":"Niraj, J., F\u00e4rkkil\u00e4, A. & D\u2019Andrea, A. D. The Fanconi anemia pathway in cancer. Annu. Rev. Cancer Biol. 3, 457\u2013478 (2019).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"57476_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molcel.2014.03.015","volume":"54","author":"D Klein Douwel","year":"2014","unstructured":"Klein Douwel, D. et al. XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP\/SLX4. Mol. Cell 54, 460\u2013471 (2014).","journal-title":"Mol. Cell"},{"key":"57476_CR48","doi-asserted-by":"publisher","unstructured":"Wu, J. H. & Jones, N. J. Assessment of DNA interstrand crosslinks using the modified alkaline comet assay. in Genetic Toxicology: Principles and Methods (eds. Parry, J. M. & Parry, E. M.) 165\u2013181 (Springer, 2012). https:\/\/doi.org\/10.1007\/978-1-61779-421-6_9.","DOI":"10.1007\/978-1-61779-421-6_9"},{"key":"57476_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0921-8777(01)00092-1","volume":"486","author":"MLG Dronkert","year":"2001","unstructured":"Dronkert, M. L. G. & Kanaar, R. Repair of DNA interstrand cross-links. Mutat. Res. DNA Repair 486, 217\u2013247 (2001).","journal-title":"Mutat. Res. DNA Repair"},{"key":"57476_CR50","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell, D. C. et al. A proteome-wide atlas of drug mechanism of action. Nat. Biotechnol. 41, 845\u2013857 (2023).","journal-title":"Nat. Biotechnol."},{"key":"57476_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11091","volume":"7","author":"S Jaber","year":"2016","unstructured":"Jaber, S., Toufektchan, E., Lejour, V., Bardot, B. & Toledo, F. p53 downregulates the Fanconi anaemia DNA repair pathway. Nat. Commun. 7, 11091 (2016).","journal-title":"Nat. Commun."},{"key":"57476_CR52","doi-asserted-by":"publisher","first-page":"13015","DOI":"10.1073\/pnas.1611228113","volume":"113","author":"J Li","year":"2016","unstructured":"Li, J. et al. Structural basis for DNA recognition by STAT6. Proc. Natl. Acad. Sci. USA 113, 13015\u201313020 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57476_CR53","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe, N. et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-Ribose) polymerase inhibition. Cancer Res. 66, 8109\u20138115 (2006).","journal-title":"Cancer Res."},{"key":"57476_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-10772-y","volume":"23","author":"S Parvin","year":"2023","unstructured":"Parvin, S. et al. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors. BMC Cancer 23, 1\u201313 (2023).","journal-title":"BMC Cancer"},{"key":"57476_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pili\u00e9","year":"2019","unstructured":"Pili\u00e9, P. G., Tang, C., Mills, G. B. & Yap, T. A. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat. Rev. Clin. Oncol. 16, 81\u2013104 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"57476_CR56","doi-asserted-by":"crossref","unstructured":"van de Kooij, B. et al. The Fanconi anemia core complex promotes CtIP-dependent end resection to drive homologous recombination at DNA double-strand breaks. Nat. Commun. 15, 7076 (2024).","DOI":"10.1038\/s41467-024-51090-6"},{"key":"57476_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/0008-5472.CAN-05-2853","volume":"66","author":"F Elstrodt","year":"2006","unstructured":"Elstrodt, F. et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 66, 41\u201345 (2006).","journal-title":"Cancer Res."},{"key":"57476_CR58","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1158\/1078-0432.CCR-15-1348","volume":"23","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. RAD51 mediates resistance of cancer stem cells to PARP inhibition in triple-negative breast cancer. Clin. Cancer Res. 23, 514\u2013522 (2017).","journal-title":"Clin. Cancer Res."},{"key":"57476_CR59","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1158\/0008-5472.CAN-12-4704","volume":"73","author":"E Charafe-Jauffret","year":"2013","unstructured":"Charafe-Jauffret, E. et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res. 73, 7290\u20137300 (2013).","journal-title":"Cancer Res."},{"key":"57476_CR60","doi-asserted-by":"publisher","first-page":"79428","DOI":"10.18632\/oncotarget.12714","volume":"7","author":"A Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves, A. et al. Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study. Oncotarget 7, 79428\u201379441 (2016).","journal-title":"Oncotarget"},{"key":"57476_CR61","doi-asserted-by":"publisher","first-page":"655","DOI":"10.15252\/emmm.201606940","volume":"9","author":"D Tosoni","year":"2017","unstructured":"Tosoni, D. et al. Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers. EMBO Mol. Med. 9, 655\u2013671 (2017).","journal-title":"EMBO Mol. Med."},{"key":"57476_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-022-00411-3","volume":"8","author":"N Tung","year":"2022","unstructured":"Tung, N. & Garber, J. E. PARP inhibition in breast cancer: progress made and future hopes. npj Breast Cancer 8, 1\u20135 (2022).","journal-title":"npj Breast Cancer"},{"key":"57476_CR63","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-05-2203","volume":"66","author":"K Leslie","year":"2006","unstructured":"Leslie, K. et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res. 66, 2544\u20132552 (2006).","journal-title":"Cancer Res."},{"key":"57476_CR64","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1073\/pnas.1400683111","volume":"111","author":"S Koganti","year":"2014","unstructured":"Koganti, S. et al. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation. Proc. Natl. Acad. Sci. USA 111, 4946\u20134951 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57476_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.171","volume":"7","author":"S De Groef","year":"2016","unstructured":"De Groef, S. et al. STAT3 modulates \u03b2-cell cycling in injured mouse pancreas and protects against DNA damage. Cell Death Dis. 7, e2272 (2016).","journal-title":"Cell Death Dis."},{"key":"57476_CR66","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong, C. et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607, 366\u2013373 (2022).","journal-title":"Nature"},{"key":"57476_CR67","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"57476_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong, P. C. et al. Inhibition of poly(ADP-Ribose) polymerase in tumors from BRCA mutation Carriers. N. Engl. J. Med. 361, 123\u2013134 (2009).","journal-title":"N. Engl. J. Med."},{"key":"57476_CR69","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/2159-8290.CD-11-0348","volume":"2","author":"YH Ibrahim","year":"2012","unstructured":"Ibrahim, Y. H. et al. PI3K inhibition impairs BRCA1\/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discov. 2, 1036\u20131047 (2012).","journal-title":"Cancer Discov."},{"key":"57476_CR70","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-15-1772","volume":"22","author":"W Mo","year":"2016","unstructured":"Mo, W. et al. mTOR inhibitors suppress homologous recombination repair and synergize with PARP inhibitors via regulating SUV39H1 in BRCA-proficient triple-negative breast cancer. Clin. Cancer Res. 22, 1699\u20131712 (2016).","journal-title":"Clin. Cancer Res."},{"key":"57476_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal5148","volume":"9","author":"C Sun","year":"2017","unstructured":"Sun, C. et al. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Sci. Transl. Med. 9, eaal5148 (2017).","journal-title":"Sci. Transl. Med."},{"key":"57476_CR72","doi-asserted-by":"publisher","first-page":"56558","DOI":"10.18632\/oncotarget.10646","volume":"7","author":"C Planque","year":"2016","unstructured":"Planque, C. et al. Pregnane X-receptor promotes stem cell-mediated colon cancer relapse. Oncotarget 7, 56558\u201356573 (2016).","journal-title":"Oncotarget"},{"key":"57476_CR73","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.cell.2022.04.034","volume":"185","author":"L Richart","year":"2022","unstructured":"Richart, L. et al. XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation. Cell 185, 2164\u20132183.e25 (2022).","journal-title":"Cell"},{"key":"57476_CR74","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s13233-015-3133-y","volume":"23","author":"S Rahmani","year":"2015","unstructured":"Rahmani, S. & Mahani, A. Szadeh Synthesis and characterization of novel poly(arylene ether)s containing 1,3,4-oxadiazole and triazole units through click chemistry. Macromol. Res. 23, 1018\u20131025 (2015).","journal-title":"Macromol. Res."},{"key":"57476_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202203505","volume":"61","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. A strategy based on aggregation-induced ratiometric emission to differentiate molecular weight of supramolecular polymers. Angew. Chem. Int. Ed. Engl. 61, e202203505 (2022).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"57476_CR76","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1039\/C5OB01353D","volume":"13","author":"A Kamal","year":"2015","unstructured":"Kamal, A. et al. Synthesis and antimicrobial potential of nitrofuran-triazole congeners. Org. Biomol. Chem. 13, 9388\u20139397 (2015).","journal-title":"Org. Biomol. Chem."},{"key":"57476_CR77","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1016\/j.bmcl.2013.10.010","volume":"23","author":"A Kamal","year":"2013","unstructured":"Kamal, A. et al. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles. Bioorg. Med. Chem. Lett. 23, 6842\u20136846 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"57476_CR78","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1093\/nar\/gki639","volume":"33","author":"PH Clingen","year":"2005","unstructured":"Clingen, P. H. et al. The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Res. 33, 3283\u20133291 (2005).","journal-title":"Nucleic Acids Res."},{"key":"57476_CR79","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70\u201378 (2009).","journal-title":"J. Immunol. Methods"},{"key":"57476_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21856","volume":"6","author":"PJ Skene","year":"2017","unstructured":"Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife 6, e21856 (2017).","journal-title":"eLife"},{"key":"57476_CR81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232\u2013250 (2022).","journal-title":"Nat. Cancer"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57476-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:58:16Z","timestamp":1741067896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57476"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57476-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4763425\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2159"}}